Insider trades
Mihael Hristos Polymeropoulos, CEO of Vanda Pharmaceuticals VNDA, has filed 14 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $1.3M. The latest trade was on 03/02.
Mihael Hristos Polymeropoulos
President and CEO
- Company
- Vanda Pharmaceuticals VNDA
- First filing
- 23/02/21
- Trades
- 25 trades
- Buys / sales
- 14 / 5
- 12-month net buying
- −$1.3M
- Last trade
- 03/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 03/02 | 03/04 | 156,235 sh | $8.17 | $1,276,439.95 | −5.5% | |
| Open-market buy | 25/08/07 | 25/08/08 | 10,000 sh | $4.15 | $41,500 | +0.4% | |
VNDA | Open-market buy | 25/05/21 | 25/05/21 | 10,000 sh2 trades | $4.40avg. | $43,995.19 | +0.4% |
| Open-market buy | 25/05/16 | 25/05/19 | 20,000 sh | $4.22 | $84,400 | +0.9% | |
VNDA | Open-market buy | 25/03/06 | 25/03/06 | 10,000 sh2 trades | $5.02avg. | $50,150 | +0.4% |
VNDA | Open-market buy | 25/03/05 | 25/03/05 | 10,000 sh2 trades | $5.02avg. | $50,200 | +0.4% |
| Open-market buy | 25/03/03 | 25/03/04 | 10,000 sh | $4.71 | $47,100 | +0.4% | |
| Open-market buy | 25/02/28 | 25/02/28 | 10,000 sh | $4.76 | $47,600 | +0.4% | |
| Open-market buy | 25/02/27 | 25/02/27 | 10,000 sh | $4.76 | $47,600 | +0.4% | |
VNDA | Open-market buy | 25/02/26 | 25/02/26 | 10,000 sh2 trades | $4.77avg. | $47,650 | +0.4% |
| Open-market buy | 25/02/25 | 25/02/25 | 10,000 sh | $4.46 | $44,600 | +0.4% | |
VNDA | Open-market sale | 24/03/04–24/03/05 | 24/03/06 | 55,172 sh2 trades | $4.19avg. | $231,257.6 | −2.9% |
VNDA | Open-market sale | 23/03/02–23/03/03 | 23/03/06 | 44,964 sh2 trades | $6.24avg. | $280,576.48 | −3.0% |